FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis-Reference-Cited by-同舟云学术

FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis

Published:2016-03-27 Issue:5 Volume:173 Page:769-778
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

May Frauke¹,Krupka Jennifer¹,Fries Marion¹,Thielmann Ina²,Pragst Ingo¹,Weimer Thomas¹,Panousis Con³,Nieswandt Bernhard²,Stoll Guido⁴,Dickneite Gerhard¹,Schulte Stefan¹,Nolte Marc W.¹

Affiliation:

1. CSL Behring GmbH; Marburg Germany

2. Chair of Vascular Medicine; University Hospital Wuerzburg and Rudolf Virchow Centre for Experimental Biomedicine; Wuerzburg Germany

3. CSL Limited; Bio21 Institute; Parkville Victoria Australia

4. Department of Neurology; University Hospital Wuerzburg; Wuerzburg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13990/fullpdf

Reference42 articles.

1. A synthetic factor XIIa inhibitor blocks selectively intrinsic coagulation initiation;Baeriswyl;ACS Chemical Biology,2015

2. Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass;Baig;Annals of Thoracic Surgery,2007

3. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures;Bendszus;The Lancet Neurology,2006

4. A ride with ferric chloride;Brill;Journal of Thrombosis and Haemostasis,2011

5. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo;Brühl;Journal of Experimental Medicine,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steps Toward Recapitulating Endothelium: A Perspective on the Next Generation of Hemocompatible Coatings;Macromolecular Bioscience;2024-07-29

2. The current landscape of factor XI inhibitors;Thrombosis Update;2024-06

3. New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants;ACS Omega;2024-02-22

4. Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation;Frontiers in Pharmacology;2023-12-19

5. Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated Coagulation;Seminars in Nephrology;2023-11